"Tailored junior capital
for the mid-market"
Labor Med
Funds advised by Syntaxis provided mezzanine capital for the acquisition by Advent International of LaborMed, the largest independent generics manufacturer in Romania. Founded in 1991, Labor Med’s initial focus was on building its portfolio on cardiovascular and central nervous systems treatments, but has since transformed itself into a speciality pharmaceutical and consumer healthcare business offering a mix of high profile OTC branded products as well as modern prescription products across the key Central European markets.
Company Profile
Company
LaborMed
Geography
Romania
Investment Date
February 2008
Sector
Pharmaceuticals
Transaction Type
LBO
Equity partner
Advent International
